Veracyte (VCYT) News Today $42.24 -1.09 (-2.52%) (As of 12/17/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Lord Abbett & CO. LLC Purchases New Holdings in Veracyte, Inc. (NASDAQ:VCYT)Lord Abbett & CO. LLC acquired a new position in Veracyte, Inc. (NASDAQ:VCYT - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 279,032 shares of the biotechnology company's stock, valued atDecember 17 at 5:11 AM | marketbeat.comFmr LLC Boosts Stock Holdings in Veracyte, Inc. (NASDAQ:VCYT)Fmr LLC raised its holdings in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 33.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 65,977 shares of the biotechnology company's stock after purchasing anDecember 15 at 3:21 AM | marketbeat.comWhy Veracyte, With 55% Growth In 2024, Is An Outlier In Cancer DiagnosticsDecember 14, 2024 | yahoo.comJane Street Group LLC Raises Holdings in Veracyte, Inc. (NASDAQ:VCYT)Jane Street Group LLC boosted its stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 276.4% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 301,652 shares of the biotechnology company's stockDecember 13, 2024 | marketbeat.comVeracyte (VCYT) Shares Rebounded in Q3December 12, 2024 | finance.yahoo.comNeo Ivy Capital Management Acquires New Holdings in Veracyte, Inc. (NASDAQ:VCYT)Neo Ivy Capital Management acquired a new position in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 24,116 shares of the biotechnology company's stock, valued atDecember 12, 2024 | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) Stock Holdings Decreased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lessened its position in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 10.6% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 144,404 shares of the biotechnologDecember 12, 2024 | marketbeat.comThose who invested in Veracyte (NASDAQ:VCYT) a year ago are up 68%December 11, 2024 | uk.finance.yahoo.comIf You Invested $1000 in Veracyte a Decade Ago, This is How Much It'd Be Worth NowDecember 11, 2024 | msn.comVeracyte: Getting FrothyDecember 10, 2024 | seekingalpha.comZacks Investment Management Takes $1.12 Million Position in Veracyte, Inc. (NASDAQ:VCYT)Zacks Investment Management purchased a new stake in Veracyte, Inc. (NASDAQ:VCYT - Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 32,995 shares of the biotechnology company's stock, valued atDecember 10, 2024 | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) Shares Sold by Wellington Management Group LLPWellington Management Group LLP decreased its position in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 38.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,232,844 shares of the bioteDecember 10, 2024 | marketbeat.comCerity Partners LLC Takes $431,000 Position in Veracyte, Inc. (NASDAQ:VCYT)Cerity Partners LLC bought a new position in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 12,672 shares of the biotechnology company's stock, valued atDecember 9, 2024 | marketbeat.com48,193 Shares in Veracyte, Inc. (NASDAQ:VCYT) Purchased by XTX Topco LtdXTX Topco Ltd acquired a new stake in Veracyte, Inc. (NASDAQ:VCYT - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 48,193 shares of the biotechnology company's stock, valued at approximately $1,640,0December 8, 2024 | marketbeat.comVerition Fund Management LLC Acquires Shares of 38,657 Veracyte, Inc. (NASDAQ:VCYT)Verition Fund Management LLC acquired a new stake in Veracyte, Inc. (NASDAQ:VCYT - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 38,657 shares of the biotechnology company's stock, valuedDecember 8, 2024 | marketbeat.comInsider Sell Alert: Phillip Febbo Sells Shares of Veracyte Inc (VCYT)December 7, 2024 | gurufocus.comBenjamin Edwards Inc. Has $971,000 Holdings in Veracyte, Inc. (NASDAQ:VCYT)Benjamin Edwards Inc. grew its holdings in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 13,351.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 28,517 shares of the biotechnology cDecember 7, 2024 | marketbeat.comVeracyte’s Decipher Prostate Test Is Now the Only Gene Expression Test Recommended in NCCN® Prostate Cancer GuidelinesDecember 6, 2024 | finance.yahoo.comGoldman Sachs Downgrades Veracyte (VCYT)December 6, 2024 | msn.comVeracyte (VCYT) was downgraded to a Hold Rating at Goldman SachsDecember 6, 2024 | markets.businessinsider.comBNP Paribas Financial Markets Buys 80,145 Shares of Veracyte, Inc. (NASDAQ:VCYT)BNP Paribas Financial Markets increased its holdings in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 438.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 98,422 shares of the biotechnology company's stock afteDecember 6, 2024 | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) Shares Sold by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. trimmed its position in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 3.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 735,007 shares of the biotechnology company's stock afteDecember 6, 2024 | marketbeat.comVeracyte's Decipher Prostate Test Is Now the Only Gene Expression Test Recommended in NCCN® Prostate Cancer GuidelinesDecember 5, 2024 | businesswire.comInsider Selling: Veracyte, Inc. (NASDAQ:VCYT) CAO Sells 956 Shares of StockDecember 5, 2024 | insidertrades.comErste Asset Management GmbH Acquires Shares of 17,000 Veracyte, Inc. (NASDAQ:VCYT)Erste Asset Management GmbH acquired a new stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 17,000 shares of the biotechnology company's stoDecember 5, 2024 | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) Receives Average Rating of "Moderate Buy" from AnalystsVeracyte, Inc. (NASDAQ:VCYT - Get Free Report) has received an average rating of "Moderate Buy" from the nine brokerages that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation and eight have assigned a buy recommendDecember 5, 2024 | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) Shares Sold by Parkman Healthcare Partners LLCParkman Healthcare Partners LLC decreased its holdings in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 38.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 129,260 shares of the biotechnology coDecember 4, 2024 | marketbeat.comPDT Partners LLC Makes New $2.38 Million Investment in Veracyte, Inc. (NASDAQ:VCYT)PDT Partners LLC acquired a new stake in Veracyte, Inc. (NASDAQ:VCYT - Free Report) in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 69,975 shares of the biotechnology company's stock, valued at approximately $2,382,000.December 1, 2024 | marketbeat.com15,266 Shares in Veracyte, Inc. (NASDAQ:VCYT) Acquired by Vinva Investment Management LtdVinva Investment Management Ltd acquired a new stake in Veracyte, Inc. (NASDAQ:VCYT - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 15,266 shares of the biotechnology company's stock, valued at approxiDecember 1, 2024 | marketbeat.comInsider Sell Alert: Jonathan Wygant Sells Shares of Veracyte Inc (VCYT)November 30, 2024 | gurufocus.comInsider Selling: Veracyte, Inc. (NASDAQ:VCYT) CAO Sells 5,032 Shares of StockNovember 30, 2024 | insidertrades.comIntech Investment Management LLC Invests $723,000 in Veracyte, Inc. (NASDAQ:VCYT)Intech Investment Management LLC bought a new position in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 21,229 shares of the biotechnology company's stock, valued at approximatelNovember 30, 2024 | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) CAO Sells $215,822.48 in StockVeracyte, Inc. (NASDAQ:VCYT - Get Free Report) CAO Jonathan Wygant sold 5,032 shares of the company's stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $42.89, for a total value of $215,822.48. Following the transaction, the chief accounting officer now directly owns 42,313 shares in the company, valued at approximately $1,814,804.57. The trade was a 10.63 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link.November 29, 2024 | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) Holdings Raised by Eventide Asset Management LLCEventide Asset Management LLC lifted its stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 20.2% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 677,883 shares of the bioNovember 29, 2024 | marketbeat.comFisher Asset Management LLC Reduces Stock Position in Veracyte, Inc. (NASDAQ:VCYT)Fisher Asset Management LLC trimmed its position in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 1.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 877,760 shares of the biotechnology company's stock after sNovember 27, 2024 | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) Shares Sold by Advantage Alpha Capital Partners LPAdvantage Alpha Capital Partners LP reduced its stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 45.2% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 25,066 shares of tNovember 26, 2024 | marketbeat.comAlgert Global LLC Increases Holdings in Veracyte, Inc. (NASDAQ:VCYT)Algert Global LLC raised its stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 411.1% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 201,697 shares of the biotechnology company's stock after buyingNovember 24, 2024 | marketbeat.comPrincipal Financial Group Inc. Lowers Position in Veracyte, Inc. (NASDAQ:VCYT)Principal Financial Group Inc. decreased its stake in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 32.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 30,486 shares of the biotechnoNovember 24, 2024 | marketbeat.comJennison Associates LLC Sells 15,581 Shares of Veracyte, Inc. (NASDAQ:VCYT)Jennison Associates LLC cut its stake in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 3.9% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 385,503 shares of the biotechnology company's stock after selling 15,581November 23, 2024 | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) Position Boosted by Connor Clark & Lunn Investment Management Ltd.Connor Clark & Lunn Investment Management Ltd. grew its holdings in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 288.6% in the third quarter, according to its most recent filing with the SEC. The firm owned 360,871 shares of the biotechnology company's stock after acquiring an additionalNovember 22, 2024 | marketbeat.comSegall Bryant & Hamill LLC Has $15.12 Million Stock Holdings in Veracyte, Inc. (NASDAQ:VCYT)Segall Bryant & Hamill LLC increased its stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 19.0% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 444,299 shares of the biotechnology company's stock after buying an additional 71,086 shares durinNovember 21, 2024 | marketbeat.com52,519 Shares in Veracyte, Inc. (NASDAQ:VCYT) Purchased by Phocas Financial Corp.Phocas Financial Corp. acquired a new stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 52,519 shares of the biotechnology company's stock, valueNovember 20, 2024 | marketbeat.comVeracyte price target raised to $28 from $26 at Morgan StanleyNovember 19, 2024 | markets.businessinsider.comVeracyte (NASDAQ:VCYT) Given New $28.00 Price Target at Morgan StanleyMorgan Stanley raised their price target on Veracyte from $26.00 to $28.00 and gave the stock an "underweight" rating in a research note on Monday.November 18, 2024 | marketbeat.comAssetmark Inc. Has $93,000 Stock Position in Veracyte, Inc. (NASDAQ:VCYT)Assetmark Inc. decreased its stake in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 86.9% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 2,744 shares of the biotechnology company's stock after selling 18,229 shares during theNovember 18, 2024 | marketbeat.comState of New Jersey Common Pension Fund D Has $2.09 Million Position in Veracyte, Inc. (NASDAQ:VCYT)State of New Jersey Common Pension Fund D decreased its holdings in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 31.4% in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 61,354 shares of the biotechnology company's stock aftNovember 16, 2024 | marketbeat.comVeracyte initiated with an Outperform at Wolfe ResearchNovember 16, 2024 | markets.businessinsider.comVeracyte initiated with an Outperform at Wolfe on growth, margin potentialNovember 16, 2024 | markets.businessinsider.comVeracyte (NASDAQ:VCYT) Now Covered by Analysts at Wolfe ResearchWolfe Research assumed coverage on Veracyte in a research report on Friday. They set an "outperform" rating and a $50.00 price objective on the stock.November 15, 2024 | marketbeat.comInsider Sale: CFO Rebecca Chambers Sells Shares of Veracyte Inc (VCYT)November 14, 2024 | gurufocus.com Get Veracyte News Delivered to You Automatically Sign up to receive the latest news and ratings for VCYT and its competitors with MarketBeat's FREE daily newsletter. Email Address Hiding in the Bible (Ad)New documentary reveals the lost wealth-building secret hidden deep within ancient religious texts from almost every civilization… an investment one expert says is “so perfect that only God could have created it.” Watch it now to discover how this asset that you’ve likely never considered before can produce returns so safe, secure, and endless it is nothing short of miraculous. This is the untold, true story of God’s Investment. VCYT Media Mentions By Week VCYT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VCYT News Sentiment▼0.850.75▲Average Medical News Sentiment VCYT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VCYT Articles This Week▼105▲VCYT Articles Average Week Get Veracyte News Delivered to You Automatically Sign up to receive the latest news and ratings for VCYT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Hims & Hers Health News Today Guardant Health News Today Option Care Health News Today Sotera Health News Today BrightSpring Health Services News Today LifeStance Health Group News Today Surgery Partners News Today Concentra Group Holdings Parent News Today Privia Health Group News Today Ardent Health Partners News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VCYT) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veracyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veracyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VCYT Stock Alerts